← All trials
NCT02737189
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2016
- Primary completion
- Sep 30, 2021
- Completion date
- Jun 30, 2022
- First posted
- Apr 13, 2016
- Last posted
- Jun 1, 2022
- Enrollment
- 217
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Capital Medical UniversityLead sponsor
- Nantong UniversityCollaborator
- Baotou Medical UniversityCollaborator
- Capital Medical UniversityCollaborator
- Capital Medical UniversityCollaborator
- Changhai HospitalCollaborator
- China Three Gorges University, Yichang, ChinaCollaborator
- Hebei UniversityCollaborator
- Henan Provincal People's HospitalCollaborator
- Liaocheng People's HospitalCollaborator
- Linyi People's HospitalCollaborator
- Luoyang Central HospitalCollaborator
- Guangxi Medical UniversityCollaborator
- Nanyang Central HospitalCollaborator
- Peking UniversityCollaborator
- Soochow UniversityCollaborator
- Shengli Oilfield Central HospitalCollaborator
- Guizhou Medical UniversityCollaborator
- Dalian Medical UniversityCollaborator
- Shanxi Medical UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Jinlin UniversityCollaborator
- The First People's Hospital of ChangzhouCollaborator
- Tianjin Huanhu HospitalCollaborator
- People's Liberation Army of ChinaCollaborator
- Capital Medical UniversityOverall official - principal investigator
- Zhangzhou Municipal Hospital of Fujian ProvinceCollaborator
- Capital Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.